Institutional investors hold a majority ownership of ABBV through the 70.32% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2016, these large investors purchased a net $16.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VANGUARD INVESTMENTS AUSTRALIA L... Bought 437.6 Thousand shares of AbbVie
ETHENEA INDEPENDENT INVESTORS SA Bought 350.0 Thousand shares of AbbVie
SIMPLEX TRADING LLC Bought 249.8 Thousand shares of AbbVie